Parallel Advisors, LLC - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2022$28,0003,047
+6383.0%
0.00%
Q4 2021$0
-100.0%
470.0%0.00%
Q3 2021$1,0000.0%470.0%0.00%
Q2 2021$1,000
-97.5%
47
-97.7%
0.00%
-100.0%
Q1 2021$40,000
+100.0%
2,047
+85.6%
0.00%
+100.0%
Q4 2020$20,000
-59.2%
1,103
-56.7%
0.00%
-66.7%
Q3 2020$49,000
+81.5%
2,547
+143.3%
0.00%
+50.0%
Q2 2020$27,000
-70.0%
1,047
-61.2%
0.00%
-71.4%
Q4 2019$90,000
+150.0%
2,700
+80.0%
0.01%
+133.3%
Q3 2019$36,000
-2.7%
1,500
+50.0%
0.00%
-25.0%
Q1 2019$37,000
-14.0%
1,0000.0%0.00%
-33.3%
Q4 2018$43,000
+79.2%
1,000
+100.0%
0.01%
+100.0%
Q3 2018$24,000
-75.8%
500
-75.0%
0.00%
-78.6%
Q2 2018$99,000
+120.0%
2,000
+122.2%
0.01%
+100.0%
Q1 2018$45,000
+50.0%
900
+12.5%
0.01%
+40.0%
Q4 2017$30,000
-14.3%
8000.0%0.01%
-16.7%
Q3 2017$35,0008000.01%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders